Literature DB >> 3335279

Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus.

J Auwerx1, J Dequeker, R Bouillon, P Geusens, J Nijs.   

Abstract

Bone mineral content (BMC), mineral homeostasis, and diabetes control were evaluated in 31 Caucasian insulin-dependent diabetic patients (disease duration 18.3 +/- 7.7 yr, mean +/- SD) with normal kidney function. To evaluate bone mass, we performed radiogrammetry and single- and dual-photon absorptiometry. In women, a significantly lower mean BMC was found in the distal radius, at a mixed trabecular-cortical (P less than .01) and a cortical (P less than .05) site, as well as in the lumbar spine (P less than .02). In diabetic men, mean BMC was significantly reduced at the trabecularcortical (P less than .01) and cortical (P less than .05) sites of the radius but not in the lumbar spine. When expressed as densities (i.e., BMC/width or lumbar BMC/area), only the BMC/width at the radius cortical area was significantly reduced in women (P less than .05). The results of the radiogrammetry showed a larger endosteal diameter in the diabetic women, resulting in a significantly lower cortical thickness (P less than .05). Diabetic men did not show abnormalities on radiogrammetry. Diabetic patients had diminished serum calcium and phosphorus concentrations (P less than .001), whereas serum parathyroid, 25-hydroxyvitamin D3, and concentrations of both total and free 1,25-dihydroxyvitamin D3 were normal. No correlation between parameters of diabetes control (HbA1, insulin dose, and triglycerides) or calcium-regulating hormones and BMC were found. These data confirm that, despite large overlap of individual values, mean bone mass at the peripheral skeleton is significantly decreased in diabetic patients. Moreover, we report that the BMC of the lumbar spine is significantly reduced in female diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335279     DOI: 10.2337/diab.37.1.8

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

1.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

2.  CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.

Authors:  Katherine J Motyl; Michelle Raetz; Srinivasan Arjun Tekalur; Richard C Schwartz; Laura R McCabe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-23       Impact factor: 3.619

Review 3.  Bone and glucose metabolism: a two-way street.

Authors:  Katherine J Motyl; Laura R McCabe; Ann V Schwartz
Journal:  Arch Biochem Biophys       Date:  2010-08-01       Impact factor: 4.013

4.  Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria.

Authors:  A Verrotti; F Basciani; F Carle; G Morgese; F Chiarelli
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

5.  Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.

Authors:  Katherine J Motyl; Laurie K McCauley; Laura R McCabe
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

6.  Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.

Authors:  Sergiu Botolin; Marie-Claude Faugere; Hartmut Malluche; Michael Orth; Ron Meyer; Laura R McCabe
Journal:  Endocrinology       Date:  2005-05-19       Impact factor: 4.736

Review 7.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

8.  Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications.

Authors:  P Pietschmann; G Schernthaner; W Woloszczuk
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

9.  Increasing serum osteocalcin after glycemic control in diabetic men.

Authors:  S Sayinalp; O Gedik; Z Koray
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

10.  Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice.

Authors:  Katherine J Motyl; Laura R McCabe
Journal:  J Cell Physiol       Date:  2009-02       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.